Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Japan's regenerative medicine cold chain logistics market thrives on aging demographics, stringent regulations, and advanced ...

Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.

Ten children who received DB-OTO for profound genetic hearing loss due to variants of the otoferlin gene showed notable ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

In the phase 1/2 INSPIRE DUCHENNE trial, interim data showed an average microdystrophin expression of 110% among participants ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

CompareNetworks is proud to announce the publication of the first issue of Cell & Gene Therapy Review, marking a significant ...

A single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...